🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Exercise-induced muscle damage (EIMD) results from unaccustomed exercise an...
Status
Completed
Location
Seaton Center Building
Start Date
2022-08-23
Trial ID
NCT06320327
Treatments Being Tested
This is a phase 2a clinical trial performed to evaluate the efficacy of a t...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01496326
The objectives of this study are to assess short term efficacy and safety o...
Status
Unknown
Location
Faculty of Medicine, Srinakharinwirot University
Start Date
2012-12
Trial ID
NCT01794260
Treatments Being Tested
The current study was randomized, double blind, placebo-controlled, prospec...
Status
Completed
Location
Moore Clinical Research Inc
Start Date
2015-03
Trial ID
NCT02633813
Treatments Being Tested
The goal of this randomized clinical trial is to test the topical drug clas...
Status
Recruiting
Location
University of Pennsylvania
Start Date
2025-01-10
Trial ID
NCT06286397
Treatments Being Tested
This is a phase III study to investigate the safety and efficacy of PAC-140...
Status
Completed
Location
Seoul National University Hospital
Start Date
2016-11
Trial ID
NCT02965118
Treatments Being Tested
The purpose of this study is to evaluate dose response, safety, tolerabilit...
Status
Completed
Location
Helsinki University Central Hospital, Skin and Allergy Hospital
Start Date
2011-03
Trial ID
NCT01320579
Objective To assess the efficacy of the topical application of Nitric Oxide...
Status
Completed
Location
Multiple Locations
Start Date
2001-09
Trial ID
NCT02015260
Treatments Being Tested
This is an open-label, single-arm, randomized, evaluator-blinded repeat ins...
Status
Completed
Location
KGL Skin Study Center
Start Date
2021-04-12
Trial ID
NCT04882631
A Phase 2 double-blind, multi-site, placebo-controlled, parallel-group desi...
Status
Completed
Location
Queen Margaret Hospital
Start Date
2022-03-23
Trial ID
NCT06402630